Skip to content

Efficacy of resistant starch and dietary supplement in hematopoietic stem cell transplant recipients

Efficacy of resistant starch and dietary supplement in hematopoietic stem cell transplant recipients - RS study in HSCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027563
Enrollment
40
Registered
2017-06-19
Start date
2017-06-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematopoietic stem cell transplant recipients

Interventions

Start RS-rich diet and dietary supplement at the initiation of conditioning regimen, continuing through day +28.

Sponsors

Tokyo metropolitan Cancer and Infectious diseases Center, Komagome hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) HSCT recipients. 2) Ability to understand and the willingness to sign a written informed consent.

Exclusion criteria

Exclusion criteria: 1) Subjects who are at risk of aspiration. 2) Subjects who are prohibited from eating for any reason. 3) Subject who have an allergy to provided prebiotics. 4) Subjects who are diagnosed with ileus. 5) Any physical or psychological condition that, in the opinion of the investigator, would pose unacceptable risk to the patient or raise concern that the patient would not comply with protocol procedures.

Design outcomes

Primary

MeasureTime frame
Incidence and duration of severe (grade 3 or more) mucositis

Secondary

MeasureTime frame
1) Cumulative incidence of acute GVHD 2) Duration of total parenteral nutrition

Countries

Japan

Contacts

Public ContactKazuhiko Kakihana

Tokyo metropolitan Cancer and Infectious diseases Center, Komagome hospital Hematology division

kakihana@cick.jp+81-3-3823-2101

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026